Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Particulate form
Patent
1989-05-02
1993-03-09
Page, Thurman K.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Particulate form
424 7808, 424493, 514 23, A61K 916, A61K 3174
Patent
active
051925516
ABSTRACT:
The binding of neutral glycolipid GA1 (asialo-GM1) to a broad spectrum of enteric viruses is taught. The glycolipid can be used to pass through the gastrointestinal tract of adults and children to adsorb viral particles and remove them from the body. The glycolipid may be used alone or bound to a non-absorbable resin or matrix.
REFERENCES:
patent: 4161516 (1979-07-01), Bell
patent: 4315001 (1982-02-01), Blough
patent: 4762822 (1988-08-01), Ettinger
patent: 4786592 (1988-10-01), Deal
patent: 4859769 (1989-08-01), Karlsson
patent: 4906562 (1990-03-01), Hellstrom
Taki, et al., J. Biochem, 91:1813-1816 (1982), entitled: "Simple Purification Method for Anti-Glycolipid Antibody Using Polystyrene Latex Beads Coated with Gangliotetraosylceramide".
Holmgren, et al., Eur. J. Biochem., 106:371-379 (1980), entitled: "Polystyrene-Adsorbed gangliosides for Investigation of the Structure of the Tetanus-Toxin Receptor".
Willoughby et al., Pediactric Research, vol. 25, No. 4, Part 2, (1989) Entitled: "Rotaviruses and Other Enteric Viruses Specifically Bind to Asialo GMA (GA.sub.1)".
Tiemeyer et al., "Ganglioside-Specific Binding Protein on Rat Brain Membranes," J. Biol. Chem. (1989), 264:1671-1681.
Krivan et al., "Many Pulmonary Pathogenic Bacteria Bind Specifically to the Carbonhydrate Sequence GalNAcb1-4Gal Found in Some Glycolipids," Proc. Natl. Acad. Sci. USA (1988), 85:6157-6161.
Willoughby et al., "SA11 Rotavirus is Specifically Inhibited by an Acetylated Sialic Acid," abstract from Society for Pediatric Research meetings, Apr., 1988, in Washington, D.C.
Yolken et al., "Sialic Acid Glycoproteins Inhibit in Vitro and In Vivo Replication of Rotaviruses," J. Clin. Invest. (1987), 79:148-154.
Flores et al, "The Role of Rotaviruses in Pediatric Diarrhea," Pediatric Infectious Disease (1986), 5:S53-S62.
Hill et al., "Use of Oral Gentamicin, Metronidazole, and Cholestyramine in the Treatment of Severe Persistent Diarrhea in Infants," Pediarics (1986), 77:477-481.
Moss et al., "Functional Incorporation of Ganglioside into Intact Cells: Induction of choleragen Responsiveness," Proc. Natl. Acad. Sci. USA (1976) 73:1034-1037.
Fields, "Molecular Basis of Reovirus Virulence," Archives of Virology (1982) 71:95-107.
Magnani et al., "Detection of Glycolipid Ligands by Direct binding of Carbohydrate-Binding Proteins to Thin-Layer Chromatograms," Methods in Enzymology (1982), 83:235-241.
Dahms et al., "Ganglioside Composition is Regulated During Differentiation in the Neuroblastoma.times.Glioma Hybrid Cell Line HG108-15," J. Neuroscience (1983), 3:806-817.
Umesaki, "Immunohistochemical and Biochemical Demonstration of the Change in Glycolipid Composition of the Intestinal Epithelial Cell Surface in Mice in Relation to Epithelial Cell Differentiation and Bacterial Association," J. Biochem. Cytochem. (1981), 32:299-304.
Bishop et al., "Virus Particles in Epithelial Cells of Duodenal Mucosa From with Acute Non-Bacterial Gastroenteritis," Lancet (1973), pp. 1281-1283.
Willoughby, Jr. Rodney E.
Yolken Robert H.
Johns Hopkins University
Kishore G. S.
Page Thurman K.
LandOfFree
Neutral glycolipid as an adsorbent for enteric viral pathogens does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Neutral glycolipid as an adsorbent for enteric viral pathogens, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Neutral glycolipid as an adsorbent for enteric viral pathogens will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-209718